Canopy Growth Corporation (CGC): Price and Financial Metrics

Canopy Growth Corporation (CGC): $10.71

-0.35 (-3.16%)

POWR Rating

Component Grades














  • CGC scores best on the Growth dimension, with a Growth rank ahead of 58.16% of US stocks.
  • CGC's strongest trending metric is Growth; it's been moving down over the last 52 weeks.
  • CGC's current lowest rank is in the Value metric (where it is better than 6.54% of US stocks).

CGC Stock Summary

  • CGC's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 0.19 -- higher than just 0.95% of US-listed equities with positive expected earnings growth.
  • With a year-over-year growth in debt of 202.19%, Canopy Growth Corp's debt growth rate surpasses 95.18% of about US stocks.
  • Over the past twelve months, CGC has reported earnings growth of -2,370.68%, putting it ahead of just 0.91% of US stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Canopy Growth Corp are PINC, LBTYA, LILA, ESGC, and DRH.
  • CGC's SEC filings can be seen here. And to visit Canopy Growth Corp's official web site, go to

CGC Price Target

For more insight on analysts targets of CGC, see our CGC price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $23.58 Average Broker Recommendation 2 (Hold)

CGC Stock Price Chart Interactive Chart >

Price chart for CGC

CGC Price/Volume Stats

Current price $10.71 52-week high $56.50
Prev. close $11.06 52-week low $10.27
Day low $10.27 Volume 9,521,300
Day high $11.17 Avg. volume 5,017,087
50-day MA $13.25 Dividend yield N/A
200-day MA $21.79 Market Cap 4.22B

Canopy Growth Corporation (CGC) Company Bio

Canopy Growth Corporation is a diversified cannabis and cannabinoid-based consumer product company, offering customers a variety of options in dried flower oil, softgel capsule, infused beverage, edible, and topic formats. Spectrum Therapeutics is the company’s global medical brand, offering a full range of products. Canopy Growth markets products in the United States, Canada, Japan, and throughout Europe and has established relationships with companies such as BioSteel Sports Nutrition and Constellation Brands. The company is headquartered in Smith Falls, Canada and has a workforce of approximately 3,000 employees. Canopy Growth was founded in 2013 and David Klein has served as the company’s Chief Executive Officer since 2020.

CGC Latest News Stream

Event/Time News Detail
Loading, please wait...

CGC Latest Social Stream

Loading social stream, please wait...

View Full CGC Social Stream

Latest CGC News From Around the Web

Below are the latest news stories about Canopy Growth Corp that investors may wish to consider to help them evaluate CGC as an investment opportunity.

The Reason I Was Wrong on Pot Stocks Is Why I’m Right About This

Cannabis is a losing ball game – because you get into price wars where everyone loses.

Luke Lango on InvestorPlace | November 27, 2021

Any Reason To Buy Canopy Growth After Executive Changes?

Canadian pot producer Canopy Growth this month announced two executive departures, after pushing back its profitability targets. Canopy on Friday said that CFO Mike Lee and Chief Product Officer Rade Kovacevic would leave Canopy on Dec. 31. Canopy said the changes were "designed to drive execution" toward its priorities.

Yahoo | November 24, 2021

Jefferies Keeps a Hold Rating on Canopy Growth (CGC)

In a report released today, Owen Bennett from Jefferies maintained a Hold rating on Canopy Growth (CGC – Research Report). The company's shares closed last Monday at $11.65, close to its 52-week low of $11.31. According to, Bennett has currently 0 stars on a ranking scale of 0-5 stars, with an average return of -4.6% and a 36.5% success rate. Bennett covers the Basic Materials sector, focusing on stocks such as Green Thumb Industries, OrganiGram Holdings, and Curaleaf Holdings. Currently, the analyst consensus on Canopy Growth is a Hold with an average price target of $13.62, representing a 10.9% upside.

Catie Powers on TipRanks | November 23, 2021

How to Rinse and Repeat With Tilray Stock for an Easy Win

TLRY stock moves fast short term, but the real story needs years to develop.

Nicolas Chahine on InvestorPlace | November 23, 2021

Tilray Remains a Solid Pot Play

The market's still skeptical about TLRY stock and other cannabis names, but this factor may work in your favor.

Thomas Niel on InvestorPlace | November 22, 2021

Read More 'CGC' Stories Here

CGC Price Returns

1-mo -19.17%
3-mo -38.62%
6-mo -55.84%
1-year -59.81%
3-year -68.08%
5-year 25.10%
YTD -56.53%
2020 16.83%
2019 -21.51%
2018 13.58%
2017 246.87%
2016 217.06%

Continue Researching CGC

Here are a few links from around the web to help you further your research on Canopy Growth Corp's stock as an investment opportunity:

Canopy Growth Corp (CGC) Stock Price | Nasdaq
Canopy Growth Corp (CGC) Stock Quote, History and News - Yahoo Finance
Canopy Growth Corp (CGC) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7736 seconds.